India fights back: COVID-19 doubling time increases from 25.5 to 70.4 days

Zydus begins human trials for potential COVID-19 vaccine

By Administrator_India

Capital Sands

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies.

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Leave a Reply

Your email address will not be published. Required fields are marked *